ribonucleic acid interference


Also found in: Acronyms.

ribonucleic acid interference (RNAi),

the function of small RNA molecules to suppress DNA transcription, thereby regulating gene expression.
References in periodicals archive ?
Keywords in this release: ribonucleic acid interference, RNAi, siRNA, shRNA, miRNA, World, in-vitro delivery, transfection reagents, in-vivo delivery, HeLa cells, polymerase chain reaction, PCR, messenger RNA, mRNA, gene-silencing technique, post-transcriptional function, protein knockdown, phenotypic alteration, functional genomics, western blot kits, research, information, market, trends, technology, service, forecast, market share
CytRx Corporation is a biopharmaceutical research and development company engaged in the development of products, primarily in the area of small molecules and ribonucleic acid interference (RNAi).
While ribonucleic acid interference (RNAi) offers a fresh approach to drug discovery, validation, and delivery, current research efforts are geared toward improving target specificity.
Kriegsman can discuss whether Ribonucleic Acid Interference (RNAi), a process developed by CytRx, is the key to saving lives by "turning off" the genes that causes diabetes.
30 /PRNewswire-FirstCall/ -- CytRx Corporation , a biopharmaceutical company engaged in the development and commercialization of human therapeutics primarily in the area of small molecules and ribonucleic acid interference (RNAi or gene silencing), today announced that preliminary interim results from a novel polyvalent DNA + protein HIV vaccine Phase I clinical trial conducted at the University of Massachusetts Medical School will be presented at the AIDS Vaccine 2005 International Conference being held September 6-9, 2005 in Montreal, Canada at the Le Centre Sheraton Montreal Hotel.
LOS ANGELES, July 18 /PRNewswire-FirstCall/ -- CytRx Corporation , a biopharmaceutical company engaged in the development and commercialization of human therapeutics primarily in the area of small molecules and ribonucleic acid interference (RNAi), is "stepping up to the plate" with former Major League pitcher Tommy John (Dodgers/Yankees) and the Greater Los Angeles Chapter of the ALS Association to hold the CytRx "Strike Out Lou Gehrig's Disease" All-Star Tournament July 23 - 30, 2005.
LOS ANGELES, June 29 /PRNewswire-FirstCall/ -- CytRx Corporation , a biopharmaceutical company engaged in the development and commercialization of human therapeutics primarily in the area of small molecules and ribonucleic acid interference (RNAi), today announced that Jack Barber, Ph.